Oral small molecule GLP-1 receptor agonist

Danuglipron 300 mg tablet

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

DANU_PO_300MG_OTHER

Mechanism: Nonpeptide GLP-1 receptor agonist (orforglipron; danuglipron; lotiglipron; aleniglipron and others)
Trials: 0
Participants in these arms: 0

All doses pooled: Danuglipron tablet
Danuglipron 200 mg oral twice daily
Danuglipron 80 mg oral twice daily
Danuglipron 140 mg tablet twice daily
Danuglipron 40 mg oral twice daily
Danuglipron 120 mg oral twice daily
Danuglipron 160 mg oral twice daily
Danuglipron 2.5 mg tablet twice daily
Danuglipron 10 mg tablet twice daily
Danuglipron 3 mg tablet
Danuglipron 10 mg tablet
Danuglipron 30 mg tablet
Danuglipron 100 mg tablet

Danuglipron 300 mg tablet

Related

Trials